WKN: | A1J84E |
ISIN: | US00287Y1091 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Pharma |
Weshalb die Abbvie-Aktie
ein A-Rating hat,
erfahren Sie im Performance-Check
vom 23. Oktober 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2014 | 38,24 | 55,42 | 44,93% |
2 | 2021 | 85,51 | 119,98 | 40,31% |
3 | 2017 | 59,33 | 81,88 | 38,01% |
4 | 2022 | 119,98 | 152,14 | 26,80% |
5 | 2024 | 139,20 | 171,00 | 22,84% |
6 | 2025 | 171,00 | 198,80 | 16,26% |
7 | 2016 | 54,18 | 59,33 | 9,51% |
8 | 2020 | 80,20 | 85,51 | 6,62% |
9 | 2019 | 78,78 | 80,20 | 1,80% |
10 | 2015 | 55,42 | 54,18 | -2,24% |
11 | 2018 | 81,88 | 78,78 | -3,79% |
12 | 2023 | 152,14 | 139,20 | -8,51% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2023 | 152,14 | 139,20 | -8,51% |
2 | 2018 | 81,88 | 78,78 | -3,79% |
3 | 2015 | 55,42 | 54,18 | -2,24% |
4 | 2019 | 78,78 | 80,20 | 1,80% |
5 | 2020 | 80,20 | 85,51 | 6,62% |
6 | 2016 | 54,18 | 59,33 | 9,51% |
7 | 2025 | 171,00 | 198,80 | 16,26% |
8 | 2024 | 139,20 | 171,00 | 22,84% |
9 | 2022 | 119,98 | 152,14 | 26,80% |
10 | 2017 | 59,33 | 81,88 | 38,01% |
11 | 2021 | 85,51 | 119,98 | 40,31% |
12 | 2014 | 38,24 | 55,42 | 44,93% |